
Shares of biotech co Ginkgo Bioworks DNA.N rise 3.3% to $12.41 premarket
Co says Bayer extended multi-year partnership with Ginkgo to develop new biological products for farming
DNA says the tie-up, which began in 2017, focuses on developing microbial solutions that help crops absorb nitrogen, reducing reliance on synthetic fertilizers
Bayer will retain the rights to commercialize any products that result from the partnership, co says
DNA based in Boston, develops tools to make it easier to engineer biological solutions for industries ranging from agriculture to healthcare
Up to last close, stock was up ~22% YTD